Porphyria: What Is It and Who Should Be Evaluated?

por Edel, Yonatan, Mamet, Rivka
Publicado 2018

A 25-Hour Fast Among Quiescent Hereditary Coproporphyria and Variegate Porphyria Patients is Associated With a Low Risk of Complications

por Edel, Yonatan, Mamet, Rivka, Sagy, Iftach, Snast, Igor, Kaftory, Ran, Mimouni, Tomer, Levi, Assi
Publicado 2023

Greater disease burden of variegate porphyria than hereditary coproporphyria: An Israeli nationwide study of neurocutaneous porphyrias

por Kaftory, Ran, Edel, Yonatan, Snast, Igor, Lapidoth, Moshe, Mamet, Rivka, Elis, Avishay, Hodak, Emmilia, Levi, Assi
Publicado 2021

Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?

por Goldman, Shira, Zidan, Omri, Edel, Yonatan, Schechter, Amir, Mimouni, Tomer, Hodak, Emmilia, Cohen, Sharon, Mamet, Rivka, Rozen-Zvi, Benaya, Levi, Assi
Publicado 2022